Support our Foundation of Myology project
1722 news items
Institute researchers at the 4th International Imaging in Neuromuscular Disease Conference
On 08/11/2023
The 4th International Imaging in Neuromuscular Disease Conference organized by the MYO-MRI consortium was held in Berlin, Germany, from November 5 to 7, 2023. This…
A very high risk of cardiac complications in Emery-Dreifuss muscular dystrophy
On 08/11/2023
An international consortium of researchers and clinicians investigated disorders of cardiac function and/or cardiac rhythm during the course of Emery-Dreifuss muscular dystrophy linked to the…
Neuromuscular diseases in developing countries: increasing genetic data from under-represented populations
On 07/11/2023
While most (86%) published genetic data on neuromuscular diseases comes from populations of European ancestry, the majority of affected families live in low- to middle-income…
Congenital myasthenic syndromes are common in India
On 07/11/2023
The team of clinicians at Bangalore University Hospital in southern India compiled clinical and genetic data on all cases of congenital myasthenic syndrome (CMS) diagnosed…
A founder effect identified in South Indian patients with beta-sarcoglycanopathy
On 06/11/2023
Beta sarcoglycanopathy is one of the four forms of limb-girdle myopathy associated with sarcoglycan deficiency. Indian clinicians have just identified an outbreak of this disease…
A comparative study of the extra-muscular manifestations of anti-synthetase syndrome and dermatomyositis
On 03/11/2023
As part of the MYONET patient registry, a consortium of clinicians compared the clinical and biological data of adult patients with either antisynthetase syndrome (ASys)…
ERN EURO-NMD webinar, 9th Nov. – Prof. Dr. Joachim Weis (Germany)
On 02/11/2023
Pathology of Peripheral Nerves 9 novembre 2023 – 16h heure de Paris Prof. Dr. Joachim Weis (University Hospital RWTH Aachen, Germany) Inscription : https://zoom.us/webinar/register/WN_GJo64JBoRxiF0Fau5sfzhQ Organisé…
Clear mitochondrial abnormalities and dermatomyositis: a case report
On 02/11/2023
A team of Italian clinicians report the observation of a 77-year-old woman presenting with a classic picture of dermatomyositis (DM) with positive anti-Mi-2 autoantibodies: study…
Russian success with tofacitinib in FOP
On 02/11/2023
Treatment with tofacitinib 5 mg twice daily was evaluated in 13 children with chronic fibrodysplasia ossificans aged 2.2 to 19.6 years: it reduced the mean…
The French Cannemuss study confirms the efficacy of anti-Covid-19 messenger RNA vaccines in cases of amyotrophy
On 31/10/2023
As the Covid-19 booster vaccination campaign gets underway in France, a new publication of the results of the Cannemuss observational study (supported by the AFM-Téléthon…
FSHD: searching for the ideal biomarker
On 31/10/2023
British and Dutch researchers have joined forces to discover a possible biological marker for facioscapulohumeral muscular dystrophy (FSHD): in view of the disappointing and/or contradictory…
Poor quality sleep in CMT?
On 31/10/2023
The Italian Charcot-Marie-Tooth registry conducted a study of sleep and sleepiness among more than 250 patients: 56% had poor quality sleep. 23% doze off during…
First clinical results of a gene therapy for the treatment of FKRP-related LGMD
On 30/10/2023
The initial results of the ATA-100 gene therapy clinical trial for the treatment of limb-girdle muscular dystrophy linked to the FKRP gene (LGMD2I/R9) were presented…
Camptocormia and a dropped head are poor prognostic factors in certain forms of myositis
On 30/10/2023
An international consortium of clinicians coordinated by the Strasbourg Reference Centre looked at patients with inflammatory myopathy with regard to two uncommon clinical signs: camptocormia…
Challenges facing people with primary mitochondrial myopathy
On 30/10/2023
An article on primary mitochondrial myopathies has been published by the Mitochondrial Medicines Society (MMS) and the United Mitochondrial Disease Foundation (UMDF): it highlights and…
The phenotype of patients with SMA carrying 4 copies of the SMN2 gene varies significantly
On 27/10/2023
The Italian ITASMAC network dedicated to spinal muscular atrophy (SMA) studied 169 individuals, children or adults, with a homozygous deletion of the SMN1 gene and…
A bone marrow tumour discovered late after treatment with Zolgensma®: case report
On 26/10/2023
American clinicians report the observation, unique to date, of a child diagnosed with SMA in the neonatal period and then treated with gene therapy (Zolgensma®…
New tools for assessing the follow-up of two forms of muscular dystrophy
On 25/10/2023
Monitoring, either as part of the usual follow-up of patients with muscular dystrophy or as part of clinical trials, is largely based on the use…
When smartphones and AI combine to assess myasthenia gravis in real life
On 24/10/2023
UCB and Sharecare conducted a three-month prospective real-life study in the United States involving 82 patients with moderate to severe autoimmune myasthenia gravis. The participants…
A study of drug management of neurobehavioural disorders in DMD
On 24/10/2023
A team analysed the medical records (66 prescriptions) of 52 boys with Duchenne muscular dystrophy (DMD), aged 11 on average, who had received drug treatment…
